News Focus
News Focus
Followers 2
Posts 1257
Boards Moderated 0
Alias Born 07/16/2006

Re: pharma11 post# 1871

Friday, 09/29/2006 12:26:01 PM

Friday, September 29, 2006 12:26:01 PM

Post# of 4764
Pharma 11..

It is articles like this that have turned normally rational people into Carl worshipers..


..Imclone has a CEO with no background in biotech. After yesterday—Imclone does have Carl Icahn, an activist stakeholder known for aggressively pushing for corporate changes to enhance stock value. Launching proxy fights is like getting dressed in the morning for Icahn. Recently, investors who followed Icahn into the maker of the hit Grand Theft Auto video-game series Take-Two Interactive (TTWO) and Symantec (SYMC), the No. 1 anti-virus software maker, were rewarded by gains of 27% and 18% in the price of the stocks, respectively, in just a few months..

http://biotech.seekingalpha.com/article/17421

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today